These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 26605909)

  • 1. Efficacy of the cat deafening method: Co-administration of ethacrynic acid and kanamycin.
    Jang JH; Lee HS; Oh SH; Park MH
    Acta Otolaryngol; 2016; 136(3):289-92. PubMed ID: 26605909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profound hearing loss in the cat following the single co-administration of kanamycin and ethacrynic acid.
    Xu SA; Shepherd RK; Chen Y; Clark GM
    Hear Res; 1993 Nov; 70(2):205-15. PubMed ID: 8294265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of ototoxicity in the cat is related to onset of auditory function.
    Shepherd RK; Martin RL
    Hear Res; 1995 Dec; 92(1-2):131-42. PubMed ID: 8647736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ototoxic destruction by co-administration of kanamycin and ethacrynic acid in rats.
    Liu H; Ding DL; Jiang HY; Wu XW; Salvi R; Sun H
    J Zhejiang Univ Sci B; 2011 Oct; 12(10):853-61. PubMed ID: 21960349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of different deafening strategies based on ototoxic drugs on mouse animals model].
    Wróbel M; Karlik M; Szaumkssel M; Rydzanicz M; Szyfter K; Szyfter W
    Otolaryngol Pol; 2012; 66(1):56-60. PubMed ID: 22381017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ototoxic effects of the interaction between kanamycin and ethacrynic acid. Cochlear ultrastructure correlated with cochlear potentials and kanamycin levels.
    Russell NJ; Fox KE; Brummett RE
    Acta Otolaryngol; 1979; 88(5-6):369-81. PubMed ID: 532612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-administration of kanamycin and ethacrynic acid as a deafening method for acute animal experiments.
    Nourski KV; Miller CA; Hu N; Abbas PJ
    Hear Res; 2004 Jan; 187(1-2):131-3. PubMed ID: 14698094
    [No Abstract]   [Full Text] [Related]  

  • 8. Partial hearing loss in the macaque following the co-administration of kanamycin and ethacrynic acid.
    Shepherd RK; Xu SA; Clark GM
    Hear Res; 1994 Jan; 72(1-2):89-98. PubMed ID: 8150749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative relationships of the ototoxic interaction of kanamycin and ethacrynic acid.
    Brummett RE; Brown RT; Himes DL
    Arch Otolaryngol; 1979 May; 105(5):240-6. PubMed ID: 435146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transneuronal cell atrophy in the congenitally deaf white cat.
    West CD; Harrison JM
    J Comp Neurol; 1973 Oct; 151(4):377-98. PubMed ID: 4754840
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in cell proliferation in rat and guinea pig cochlea after aminoglycoside-induced damage.
    Yamasoba T; Kondo K; Miyajima C; Suzuki M
    Neurosci Lett; 2003 Aug; 347(3):171-4. PubMed ID: 12875913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of ototoxic drugs by guinea pig shiver audiometry.
    Crifò S
    Audiology; 1974; 13(4):302-10. PubMed ID: 4413766
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic effect of adeno-associated virus (AAV)-mediated ADNF-9 expression on cochlea of kanamycin-deafened guinea pigs.
    Zheng G; Zhu Z; Zhu K; Wei J; Jing Y; Duan M
    Acta Otolaryngol; 2013 Oct; 133(10):1022-9. PubMed ID: 24032567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protein derived from the fusion of TAT peptide and FNK, a Bcl-x(L) derivative, prevents cochlear hair cell death from aminoglycoside ototoxicity in vivo.
    Kashio A; Sakamoto T; Suzukawa K; Asoh S; Ohta S; Yamasoba T
    J Neurosci Res; 2007 May; 85(7):1403-12. PubMed ID: 17387707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of TMPRSS3 in the rat cochlea following kanamycin ototoxicity].
    Peng A; Ge S; Wang Q; Xie D; Wu W; Xiao Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 36(10):987-91. PubMed ID: 22086001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3.
    Wise AK; Richardson R; Hardman J; Clark G; O'leary S
    J Comp Neurol; 2005 Jun; 487(2):147-65. PubMed ID: 15880560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cochlear pathology in cats following administration of neomycin sulfate.
    Leake-Jones PA; Vivion MC
    Scan Electron Microsc; 1979; (3):983-91. PubMed ID: 524065
    [No Abstract]   [Full Text] [Related]  

  • 18. Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide.
    Versnel H; Agterberg MJ; de Groot JC; Smoorenburg GF; Klis SF
    Hear Res; 2007 Sep; 231(1-2):1-12. PubMed ID: 17475424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed electrical stimulation and BDNF application following induced deafness in rats.
    Song BN; Li YX; Han DM
    Acta Otolaryngol; 2009 Feb; 129(2):142-54. PubMed ID: 18607918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ototoxic effects of ethacrynic acid in man and animals.
    Matz GJ
    Laryngoscope; 1976 Aug; 86(8):1065-86. PubMed ID: 1084946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.